Reliability in long-term clinical studies of disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review.

<h4>Background</h4>Although relapsing-remitting multiple sclerosis (RRMS) has a chronic course, little information is known about the comparison between the disease-modifying therapies (DMT) for long-term outcomes. We aimed to conduct a systematic review of randomized clinical trial (RCT...

Full description

Bibliographic Details
Main Authors: Rosa C Lucchetta, Letícia P Leonart, Marcus V M Gonçalves, Jefferson Becker, Roberto Pontarolo, Fernando Fernandez-Llimós, Astrid Wiens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0231722